ERA Members
The European RNA Alliance (ERA) brings together European manufacturers and service providers specializing in distinct but complementary products, services and expertise across ribonucleic acids (RNA) science and technologies. Through collaboration and joint initiatives, ERA offers an integrated portfolio covering the whole range of innovative RNA applications and gives access to high-quality Made-in-Europe solutions.
Anemocyte
Anemocyte is an Italian Biotech Manufacturing Organization offering 25 years of development and manufacturing expertise, from R&D to GMP, in the field of nucleic acids. Anemocyte provides comprehensive development, manufacturing, and analytical services, alongside a premium portfolio of off-the-shelf products. The company's specialized offerings include custom linearised pDNA manufacturing (R&D, HQ, and GMP grades) for mRNA production, as well as an innovative mRNA manufacturing platform based on Anemocyte's proprietary AMCAP™ technology to support next-generation vaccines and therapeutics.
Visit website
Genevia Technologies
Genevia Technologies has more than 15 years of experience in custom analysis of transcriptomics data. The company focuses on providing bioinformatics and omics data analysis services for all kinds of NGS and mass spectrometry data. Our customers include academic research groups and pharmaceutical companies globally.
Visit website
Immagina Biotechnology
IMMAGINA, The Ribosome Company. The ribosome is where genetic code becomes action, where genotype turns into phenotype. Immagina is the only functional RNA biology company built entirely around it, sitting at the intersection of translatome biomarkers, RNA liquid biopsy, translational oncology, and RNA therapeutics support. Through products, services, and co-development projects, we turn ribosome complexity into high-content, actionable data.
Visit website
Lexogen
Lexogen is a Vienna-based RNA technology company covering the entire transcriptomics workflow, from sample prep and RNA-seq library generation to bioinformatics solution, through integrated products and services. Its proprietary technologies are developed and manufactured in Vienna under ISO 13485, while its CRO services operate under ISO 13485 and GCLP standards. For nearly two decades, Lexogen enables reliable analysis of difficult, sensitive, and precious samples for clinical research, drug discovery, biomarker development, and large-scale transcriptomic studies.
Visit website
MultiplexDX
MultiplexDX is a Slovak biotech company developing molecular diagnostic technologies for precision oncology, with a focus on improving cancer diagnosis and treatment selection. The company's proprietary Multiplex8+ platform combines multiplex RNA FISH and RNA sequencing technologies to enable comprehensive biomarker analysis and generate deeper insights into tumor biology. MultiplexDX also has in-house capabilities for the design and production of custom oligonucleotides, supporting the development of molecular assays and research applications. The company provides expertise across molecular diagnostics, transcriptomics, biomarker analysis, and bioinformatics, supporting academic, clinical, and industry partners in advancing personalized medicine.
Visit website
siTOOLs Biotech
siTOOLs Biotech is a Munich-based company that develops validated high-complexity siRNA pools for precise and reliable gene silencing. They also offer an extensive portfolio of ribosomal RNA depletion reagents optimized for RNA-Seq, Ribosome Profiling, and Oxford Nanopore Sequencing, as well as customizable reagents for targeted RNA enrichment. Their tools and services provide both academic researchers and pharmaceutical companies with robust, species-flexible solutions for RNA research.
Visit website
TAmiRNA
TAmiRNA is a Viennese RNA biomarker development and service company. Founded in 2013, it has 13+ years' experience discovering, validating, and translating RNA biomarker candidates in biofluids and extracellular vesicles, supporting customers from discovery to test development under an ISO 13485-certified, IVDR-compliant quality system, reflected in hepatomiR®, Europe's first approved microRNA test. Because standard RNA-sequencing loses accuracy in biofluids, TAmiRNA's miND® spike-in controls convert reads into absolute concentrations and correct technical bias, validated across plasma, serum, CSF, and extracellular vesicles, paired with an integrated bioinformatics pipeline, making TAmiRNA the partner of choice for RNA-sequencing-based biomarker discovery in liquid biopsy.
Visit websiteWant to join?
If your company works in RNA tools, services, or bioinformatics in Europe, we would love to hear from you. Use the contact form or write to us directly by email.